I think the weakness in SP reflects Bell potters concerns that...

I think the weakness in SP reflects Bell potters concerns that GE restocking may have contributed significantly to the last reported quarters good sales results. We may have seen an effective drop from a 1000 units to 700 say. There was also a comment that GE sales have not increased as well but this may just reflect sales preferentially going to the nanosonics team directly.

In terms of outlook for any given market I think it all depends on the prior method of HLD. If the medical culture in the country is to use cidex or opa soaks then trophon is easy transition ( think US). If the "culture" is to use wipes then tristel looks good and trophon has a tougher battle on its hand with the major advantage being automated. I have no idea what they use in Japan but if its cidex soak then trophon looks good.